DM-101PX clinical trials
Also written DM-101PX.
How each study uses DM-101PX is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the DM-101PX studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DM-101PX
- 3
Studies by the year they started
3 studies that test it; most in 2023 (1)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Who runs them
Industry 3 · Other 0
Desentum Oy (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test DM-101PX.
- Mar 2027Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyPhase 1 · Desentum Oy
Studies
Open first, then newest update. How each study uses DM-101PX is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyRecruitingPhase 1Desentum OyNCT07898800Written as DM-101PX
- Study of DM-101PX in Adults With Birch Pollen AllergyCompletedPhase 2Desentum OyNCT07254871Written as DM-101PX
- Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic ParticipantsCompletedPhase 1Desentum OyNCT06037148Written as DM-101PX